Efficacy trial of single intake of plant derived ingredient. [g2019004]
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000037738
- Lead Sponsor
- Kao Corporation
- Brief Summary
A significant difference was observed in the primary outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 18
Not provided
(1) Diabetes mellitus (2) Taking medicine related diabetes mellitus (3) BMI<=30kg/m2 (4) Having history or presence of cardiovascular disease or cerebrovascular disease (5) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (6) Having history of resection of gastrointestinal tract (7) Thyroid deficiency (8) Heavy alcohol drinker (over 30g per day) (9) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study (10) Severe anemia (Hb <=7g/dL) (11) Food allergies for test foods (12) Planned to participate in other clinical study during current study (13) Shift worker (14) Determined to be unqualified by the physician in charge or the responsible person of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postprandial GLP-1 concentration (baseline, 30, 60, 90, 105, and 120 minutes after ingestion of a test meal)
- Secondary Outcome Measures
Name Time Method Postprandial concentration of glucose, insulin and GIP (baseline, 30, 60, 90, 105, and 120 minutes after ingestion of a test meal)